Efficacy of cefiderocol in combination with xeruborbactam versus taniborbactam against cefiderocol-resistant NDM-producing Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy · 05.11.2025 · 69 (11)
DOI: 10.1128/aac.00857-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.11.2025. Verfasst von Kaan Kocer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology, University of Lübeck and University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, beta-Lactamases, Cephalosporins, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We evaluated the in vitro activity of cefiderocol in combination with either taniborbactam or xeruborbactam against cefiderocol-resistant, bla NDM -positive Pseudomonas aeruginosa clinical isolates from Vietnam and Nigeria. Taniborbactam restored cefiderocol susceptibility in most isolates (20/21, 95.2%), while xeruborbactam had no effect. Resistance was reversed by dipicolinic acid, which confirmed New-Delhi Metallo-β-Lactamase (NDM-mediated) resistance. One isolate that was unresponsive to taniborbactam carried multiple copies of bla NDM-1 . These findings highlight the species-specific limitations of xeruborbactam in P. aeruginosa .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Microbiology, University of Lübeck and University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.
- German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.
- Vietnamese-German Centre for Medical Research (VG-CARE), Hanoi, Vietnam.
- 108 Military Central Hospital, Hanoi, Vietnam.
- Faculty of Medicine, Duy Tan University, Da Nang, Vietnam.
- Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany.
ORCID-Profile: Kaan Kocer, Truong Nhat My, Bui Tien Sy, Thirumalaisamy P Velavan, Adesola Olalekan, Dennis Nurjadi
Zitieren
APA
Kocer, K., My, T. N., Sy, B. T., Göpel, L., Velavan, T. P., Song, L. H., Peter, S., Boutin, S., Olalekan, A., & Nurjadi, D. (2025). Efficacy of cefiderocol in combination with xeruborbactam versus taniborbactam against cefiderocol-resistant NDM-producing Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 69(11). https://doi.org/10.1128/aac.00857-25
Vancouver
Kocer K, My TN, Sy BT, Göpel L, Velavan TP, Song LH, et al. Efficacy of cefiderocol in combination with xeruborbactam versus taniborbactam against cefiderocol-resistant NDM-producing Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2025;69(11). doi:10.1128/aac.00857-25
BibTeX
@article{Kocer2025,
author = {Kocer, Kaan and My, Truong Nhat and Sy, Bui Tien and Göpel, Lisa and Velavan, Thirumalaisamy P and Song, Le Huu and Peter, Silke and Boutin, Sébastien and Olalekan, Adesola and Nurjadi, Dennis},
title = {Efficacy of cefiderocol in combination with xeruborbactam versus taniborbactam against cefiderocol-resistant NDM-producing Pseudomonas aeruginosa},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {11},
doi = {10.1128/aac.00857-25}
}
EUVIMED